These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

308 related articles for article (PubMed ID: 27671778)

  • 1. Corticosteroids in IgA Nephropathy: Lessons from Recent Studies.
    Coppo R
    J Am Soc Nephrol; 2017 Jan; 28(1):25-33. PubMed ID: 27671778
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pro: STOP immunosuppression in IgA nephropathy?
    Pozzi C
    Nephrol Dial Transplant; 2016 Nov; 31(11):1766-1770. PubMed ID: 27515694
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Corticosteroids in IgA Nephropathy: A Retrospective Analysis from the VALIGA Study.
    Tesar V; Troyanov S; Bellur S; Verhave JC; Cook HT; Feehally J; Roberts IS; Cattran D; Coppo R;
    J Am Soc Nephrol; 2015 Sep; 26(9):2248-58. PubMed ID: 25677392
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of Two Immunosuppressive Treatment Protocols for IgA Nephropathy.
    Rauen T; Fitzner C; Eitner F; Sommerer C; Zeier M; Otte B; Panzer U; Peters H; Benck U; Mertens PR; Kuhlmann U; Witzke O; Gross O; Vielhauer V; Mann JFE; Hilgers RD; Floege J
    J Am Soc Nephrol; 2018 Jan; 29(1):317-325. PubMed ID: 29042456
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immunosuppression in IgA Nephropathy: Guideline Medicine Versus Personalized Medicine.
    Feehally J
    Semin Nephrol; 2017 Sep; 37(5):464-477. PubMed ID: 28863793
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Treatment of IgA nephropathy.
    Pozzi C
    J Nephrol; 2016 Feb; 29(1):21-5. PubMed ID: 26577268
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Randomized controlled clinical trial of corticosteroids plus ACE-inhibitors with long-term follow-up in proteinuric IgA nephropathy.
    Manno C; Torres DD; Rossini M; Pesce F; Schena FP
    Nephrol Dial Transplant; 2009 Dec; 24(12):3694-701. PubMed ID: 19628647
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Use of corticosteroids in Norwegian patients with immunoglobulin a nephropathy progressing to end-stage kidney disease: a retrospective cohort study.
    Rivedal M; Haaskjold YL; Eikrem Ø; Bjørneklett R; Marti HP; Knoop T
    BMC Nephrol; 2024 Jan; 25(1):42. PubMed ID: 38287343
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Considerations on the treatment of IgA nephropathy on the basis of the results of the latest studies (STOP-IgAN, TESTING, NEFIGAN)].
    Nagy J; Sági B; Máté J; Vas T; Kovács T
    Orv Hetil; 2017 Dec; 158(49):1946-1952. PubMed ID: 29199436
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Changes in Proteinuria and Side Effects of Corticosteroids Alone or in Combination with Azathioprine at Different Stages of IgA Nephropathy.
    Sarcina C; Tinelli C; Ferrario F; Pani A; De Silvestri A; Scaini P; Del Vecchio L; Alberghini E; Buzzi L; Baragetti I; Pozzi C
    Clin J Am Soc Nephrol; 2016 Jun; 11(6):973-981. PubMed ID: 27129712
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Treatment of IgA nephropathy: Recent advances and prospects.
    Coppo R
    Nephrol Ther; 2018 Apr; 14 Suppl 1():S13-S21. PubMed ID: 29606258
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Treatment of IgA nephropathy: corticosteroids, tonsillectomy, and mycophenolate mofetil.
    Kawamura T
    Contrib Nephrol; 2007; 157():37-43. PubMed ID: 17495435
    [TBL] [Abstract][Full Text] [Related]  

  • 13. An update on the treatment of IgA nephropathy.
    Barbour S; Feehally J
    Curr Opin Nephrol Hypertens; 2017 Jul; 26(4):319-326. PubMed ID: 28399021
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Update on treatment of immunoglobulin A nephropathy.
    Zhang YM; Zhang H
    Nephrology (Carlton); 2018 Oct; 23 Suppl 4():62-67. PubMed ID: 30298661
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [IgA nephropathy].
    Pillebout E; Vérine J
    Nephrol Ther; 2016 Jul; 12(4):238-54. PubMed ID: 27323655
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Corticosteroids pulse therapy and oral corticosteroids therapy for IgA nephropathy patients with advanced chronic kidney disease: results of a multicenter, large-scale, long-term observational cohort study.
    Tsunoda R; Usui J; Hoshino J; Fujii T; Suzuki S; Takaichi K; Ubara Y; Yamagata K
    BMC Nephrol; 2018 Sep; 19(1):222. PubMed ID: 30189860
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Treatment of IgA nephropathy with chronic renal failure].
    Pozzi C
    G Ital Nefrol; 2008; 25 Suppl 44():83-7. PubMed ID: 19048591
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Reduction of proteinuria by therapeutic intervention improves the renal outcome of elderly patients with IgA nephropathy.
    Okabayashi Y; Tsuboi N; Haruhara K; Kanzaki G; Koike K; Shimizu A; Miyazaki Y; Ohno I; Kawamura T; Ogura M; Yokoo T
    Clin Exp Nephrol; 2016 Dec; 20(6):910-917. PubMed ID: 26830548
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of the effects of hydroxychloroquine and corticosteroid treatment on proteinuria in IgA nephropathy: a case-control study.
    Yang YZ; Chen P; Liu LJ; Cai QQ; Shi SF; Chen YQ; Lv JC; Zhang H
    BMC Nephrol; 2019 Aug; 20(1):297. PubMed ID: 31382914
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical and histological risk factors for progression of IgA nephropathy: an update in children, young and adult patients.
    Coppo R
    J Nephrol; 2017 Jun; 30(3):339-346. PubMed ID: 27815919
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.